EX-99.1 2 d809535dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement,

application for quotation of additional securities

and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

   Name of entity  
Immutep Limited (IMM)  

 

   ABN

 

90 009 237 889

 

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

    1

   +Class of +securities issued or to be issued      

1.  Unlisted Performance Rights

 

2.  Ordinary Shares

 

3.  Ordinary Shares

 

4.  Ordinary Shares

        

    2

   Number of +securities issued or to be issued (if known) or maximum number which may be issued      

1.  45,000,000 Unlisted Performance Rights

 

2.  3,875,578 Ordinary Shares

 

3.  4,266,531 Ordinary Shares

 

4.  2,736,367 Ordinary Shares


    3    Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)      

1. Performance Rights

  

 

Number of performance rights

  

 

45,000,000

  

 

Vesting conditions

  

 

Based on Service Condition.

  

 

Tranche 1

  

 

15,000,000 on 1 October 2020

  

 

Tranche 2

  

 

15,000,000 on 1 October 2021

  

 

Tranche 3

  

 

15,000,000 on 1 October 2022

  

 

Expiry Date

  

 

The performance rights will expire one year after the relevant vesting date unless exercised, subject to accelerated vesting conditions.

  

 

Price of performance rights

  

 

Performance rights will be granted at no cost. Once the vesting conditions are met (or waived in exceptional circumstances), the performance rights will be exercisable at nil cost.

        

2.  Pari passu with existing Fully Paid Ordinary Shares

 

3.  Pari passu with existing Fully Paid Ordinary Shares

 

4.  Pari passu with existing Fully Paid Ordinary Shares

           
    4   

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

 

•   the date from which they do

 

•   the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

 

•   the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

     

1.  Yes, if/when the Performance Rights vest to shares

 

2.  ‘Pari Passu’ with existing Fully Paid Ordinary Shares

 

3.  ‘Pari Passu’ with existing Fully Paid Ordinary Shares

 

4.  ‘Pari Passu’ with existing Fully Paid Ordinary Shares

           
    5    Issue price or consideration      

1.  Nil

 

2.  Nil

 

3.  Nil

 

4.  Nil

    

 

 

+

See chapter 19 for defined terms.

 

Appendix 3B Page 2

   04/03/2013


    6   

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

     

1.  Unlisted Performance Rights are issued to employees under the Executive Incentive Plan

 

2.  Vesting & exercise of Performance Rights under the Executive Incentive Plan into fully paid ordinary shares.

 

3.  Mr Grant Chamberlain exercises 2nd tranche of his performance rights which vested to him i.e. 4,266,531 to convert to ordinary shares, in accordance with shareholder approval received at the AGM on 17 November 2017.

 

4.  Mr Pete Meyers exercises 3rd tranche of his performance rights which vested to him i.e. 2,736,367 to convert to ordinary shares, in accordance with shareholder approval received at the AGM on 25 November 2016.

        
    6a   

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b – 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

      Yes
        
    6b    The date the security holder resolution under rule 7.1A was passed       16 November 2018
        
    6c    Number of +securities issued without security holder approval under rule 7.1       Nil
        
    6d    Number of +securities issued with security holder approval under rule 7.1A       Nil
        
    6e    Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)      

3.  4,266,531 ordinary shares are issued on exercise of 2nd tranche of performance rights approved for Non-Executive Director, Mr Grant Chamberlain at the AGM on 17 November 2017.

 

4.  2,736,367 ordinary shares are issued on exercise of 3rd tranche of performance rights approved for Non-Executive Director, Mr Pete Meyers at the AGM on 25 November 2016.


    6f    Number of +securities issued under an exception in rule 7.2      

1.  45,000,000 performance rights issued under exception 9 in rule 7.2

 

2.  3,875,578 ordinary shares issued on exercising performance rights

        
    6g    If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.       Not applicable
        
    6h    If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements       Not applicable
        
    6i    Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements      

LR 7.1 - 197,097,491

 

LR 7.1A - 1,087,848

        
    7   

+Issue dates

 

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

 

Cross reference: item 33 of Appendix 3B.

      3 October 2019
        
              

Number

  

+Class

    8    Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)       3,877,122,311    Fully paid ordinary shares

 

 

+

See chapter 19 for defined terms.

 

Appendix 3B Page 4

   04/03/2013


              Number      +Class - Options
              Amount      Exercise Price     

Expiration Date

    9

   Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)        371,445,231      $ 0.0237      4 August 2020
          793,103      $ 0.057      30 October 2020
          1,026,272      $ 0.040      7 March 2021
          8,475,995      $ 0.025      4 August 2025
              Number      +Class – Warrants over NASDAQ listed American Depository Shares
              Amount      Exercise Price     

Terms

          1,553,718      US$ 2.50      Each Warrant entitles the holder to purchase 1 ADS (where one ADS = 100 Ordinary Shares) at the exercise price and is exercisable immediately. Each Warrant will expire on 5 January 2023.
          2,080,000      US$ 2.50      Each Warrant entitles the holder to purchase 1 ADS (where one ADS = 100 Ordinary Shares) at the exercise price and is exercisable immediately. Each Warrant will expire on 12 February 2022.
              Number      +Class – Performance Rights
              Amount      Type     

Expiration Date

          2,736,367        NED PRs      Each tranche of NED PRs will expire one year after Vesting Date if not exercised as indicated in the appendix 3B released on 6 December 2016.
          4,266,532        NED PRs      Each tranche of NED PRs will expire one year after Vesting Date if not exercised as indicated in the appendix 3B released on 4 December 2016.


          36,666,666        LTI      Each tranche of LTIs will expire one year after Vesting Date if not exercised as indicated in the appendix 3B released on 4 December 2017.
          5,000,000        LTI      Each tranche of LTIs will expire one year after Vesting Date if not exercised as indicated in the appendix 3B released on 4 December 2017.
          3,875,574        LTI      Each tranche of LTIs will expire one year after Vesting Date if not exercised as indicated in the appendix 3B released on 2 October 2018.
          7,500,000        NED PRs      Each tranche of NED PRs will expire one year after Vesting Date if not exercised as indicated in the appendix 3B released on 21 November 2019.
          45,000,000        LTI      Each tranche of LTIs will expire one year after the relevant vesting date unless exercised, subject to accelerated vesting conditions.
              Number      +Class – Convertible Notes
              Amount      Type     

Expiration Date

          13,750,828       
Convertible Notes each with a face value of AU$1, expiring on
4 August 2025.
             

    10

   Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)        Unchanged

Part 2 - Bonus issue or Pro rata issue

 

    11    Is security holder approval required?                  Not applicable
             
    12    Is the issue renounceable or non-renounceable?        Not applicable
             
    13    Ratio in which the +securities will be offered        Not applicable

 

 

+

See chapter 19 for defined terms.

 

Appendix 3B Page 6

   04/03/2013


14    +Class of +securities to which the offer relates       Not applicable
              
15    +Record date to determine entitlements       Not applicable
              
16    Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?       Not applicable
              
17    Policy for deciding entitlements in relation to fractions       Not applicable
              
18   

Names of countries in which the entity has security holders who will not be sent new offer documents

 

Note: Security holders must be told how their entitlements are to be dealt with.

 

Cross reference: rule 7.7.

      Not applicable
              
19    Closing date for receipt of acceptances or renunciations       Not applicable
              
20    Names of any underwriters       Not applicable
              
21    Amount of any underwriting fee or commission       Not applicable
              
22    Names of any brokers to the issue       Not applicable
              
23    Fee or commission payable to the broker to the issue       Not applicable
              
24    Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders       Not applicable
              
25    If the issue is contingent on security holders’ approval, the date of the meeting       Not applicable
              
26    Date entitlement and acceptance form and offer documents will be sent to persons entitled       Not applicable
              
27    If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders       Not applicable


    28    Date rights trading will begin (if applicable)     

Not applicable

 

       
    29    Date rights trading will end (if applicable)     

Not applicable

 

       
    30    How do security holders sell their entitlements in full through a broker?     

Not applicable

 

       
    31    How do security holders sell part of their entitlements through a broker and accept for the balance?     

Not applicable

 

       
    32    How do security holders dispose of their entitlements (except by sale through a broker)?     

Not applicable

 

       
    33    +Issue date     

Not applicable

 

 

+

See chapter 19 for defined terms.

 

Appendix 3B Page 8

   04/03/2013


Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

  

Type of +securities

(tick one)

(a)       +Securities described in Part 1
(b)      

All other +securities

 

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

 

35       If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders
36      

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

 

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

37       A copy of any trust deed for the additional +securities


Entities that have ticked box 34(b)

 

    38    Number of +securities for which +quotation is sought      

N/A

 

    
           
    39    +Class of +securities for which quotation is sought      

N/A

 

    
           
   

    40

  

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

 

•  the date from which they do

 

•  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

 

•  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

     

N/A

 

    
           
   

    41

  

Reason for request for quotation now

 

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

      N/A     
           
              

Number

  

+Class

    42

   Number and +class of all +securities quoted on ASX (including the +securities in clause 38)      

N/A

 

 

   N/A

 

 

+

See chapter 19 for defined terms.

 

Appendix 3B Page 10

   04/03/2013


Quotation agreement

 

1

+Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2

We warrant the following to ASX.

 

   

The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

   

There is no reason why those +securities should not be granted +quotation.

 

   

An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

   

Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

   

If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3

We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4

We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

  LOGO    
Sign here:       Date:   3 October 2019
  (Director/Company secretary)      
Print name:        

Tom Bloomfield

 

 

+

See chapter 19 for defined terms.

 

04/03/2013

   Appendix 3B Page 11


Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

 

Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue    3,079,008,729

Add the following:

 

•  Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

 

•  Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

 

•  Number of partly paid +ordinary securities that became fully paid in that 12 month period

 

Note:

 

•  Include only ordinary securities here – other classes of equity securities cannot be added

 

•  Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

 

•  It may be useful to set out issues of securities on different dates as separate line items

   347,637,391
Subtract the number of fully paid +ordinary securities cancelled during that 12 month period    Nil
“A”    3,426,646,120

 

 

+

See chapter 19 for defined terms.

 

Appendix 3B Page 12

   04/03/2013


Step 2: Calculate 15% of “A”
“B”   

0.15

 

[Note: this value cannot be changed]

Multiply “A” by 0.15    513,996,918
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

 

•  Under an exception in rule 7.2

 

•  Under rule 7.1A

 

•  With security holder approval under rule 7.1 or rule 7.4

 

Note:

 

•  This applies to equity securities, unless specifically excluded – not just ordinary securities

 

•  Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

 

•  It may be useful to set out issues of securities on different dates as separate line items

  

2,080,000 Warrants convertible into 2,080,000 ADS (representing 208,000,000 ordinary shares)

 

108,899,427 fully paid ordinary shares

“C”    316,899,427
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

“A” x 0.15

 

Note: number must be same as shown in Step 2

   513,996,918

Subtract “C”

 

Note: number must be same as shown in Step 3

   316,899,427
Total [“A” x 0.15] – “C”   

197,097,491

 

[Note: this is the remaining placement capacity under rule 7.1]

 

 

+

See chapter 19 for defined terms.

 

04/03/2013

   Appendix 3B Page 13


Part 2

 

Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A”

 

Note: number must be same as shown in Step 1 of Part 1

   3,426,646,120
Step 2: Calculate 10% of “A”
“D”   

0.10

 

Note: this value cannot be changed

Multiply “A” by 0.10    342,664,612
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

 

Notes:

 

•  This applies to equity securities – not just ordinary securities

 

•  Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

 

•  Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

 

•  It may be useful to set out issues of securities on different dates as separate line items

   341,576,764
“E”    341,576,764

 

+

See chapter 19 for defined terms.

 

Appendix 3B Page 14

   04/03/2013


Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

“A” x 0.10

 

Note: number must be same as shown in Step 2

   342,664,612

Subtract “E”

 

Note: number must be same as shown in Step 3

   341,576,764
Total [“A” x 0.10] – “E”   

1,087,848

 

Note: this is the remaining placement capacity under rule 7.1A

 

 

+

See chapter 19 for defined terms.

 

04/03/2013

   Appendix 3B Page 15